HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Roberta Lanzillo Selected Research
Roberta Lanzillo Research Topics
Disease
67
Multiple Sclerosis
11/2022 - 10/2005
13
Relapsing-Remitting Multiple Sclerosis
01/2022 - 04/2010
8
Progressive Multifocal Leukoencephalopathy
05/2021 - 01/2014
5
Infections
11/2022 - 01/2019
4
COVID-19
11/2022 - 10/2020
4
Cognitive Dysfunction
07/2022 - 01/2017
4
Inflammation (Inflammations)
11/2021 - 01/2019
3
Atrophy
08/2022 - 01/2016
3
Sudden Infant Death (SID)
01/2022 - 01/2020
2
Ganglion Cysts (Ganglion)
07/2022 - 12/2021
2
Atrioventricular Block
05/2021 - 09/2016
1
Breakthrough Infections
11/2022
1
Communicable Diseases (Infectious Diseases)
07/2022
1
Neurodegenerative Diseases (Neurodegenerative Disease)
07/2022
1
Glaucoma
07/2022
1
Bradycardia
05/2021
1
Starvation
01/2021
1
Neuromyelitis Optica (Devic's Disease)
11/2019
1
Bacterial Infections (Bacterial Infection)
11/2019
1
Virus Diseases (Viral Diseases)
11/2019
1
Pain (Aches)
01/2019
1
Fatigue
01/2019
1
Bacterial Pneumonia
01/2019
1
Pneumonia (Pneumonitis)
01/2019
1
Disease Progression
01/2018
1
Spontaneous Abortion (Miscarriage)
01/2018
1
Chronic Disease (Chronic Diseases)
07/2017
1
Mitochondrial Diseases (Mitochondrial Disease)
01/2017
1
Chronic Progressive Multiple Sclerosis
01/2016
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2005
1
Meningitis
10/2005
1
Rheumatoid Arthritis
10/2005
1
Encephalitis (Encephalitis, Rasmussen)
10/2005
1
Autoimmune Diseases (Autoimmune Disease)
10/2005
1
Glycogen Storage Disease Type V (McArdle's Disease)
06/2002
Drug/Important Bio-Agent (IBA)
12
Natalizumab (Tysabri)
FDA Link
11/2022 - 01/2014
10
Biomarkers (Surrogate Marker)
IBA
08/2022 - 01/2014
8
Antibodies
IBA
01/2022 - 10/2005
6
Monoclonal Antibodies
IBA
07/2022 - 01/2019
5
ocrelizumab
IBA
11/2022 - 11/2019
5
Retinaldehyde (Retinal)
IBA
07/2022 - 11/2018
5
Rituximab (Mabthera)
FDA Link
04/2021 - 11/2019
5
Interferons
IBA
01/2018 - 06/2006
4
Cladribine
FDA Link
Generic
01/2022 - 01/2020
4
Interferon beta-1a
FDA Link
11/2021 - 04/2010
4
Interferon-beta
IBA
01/2021 - 08/2015
4
Pharmaceutical Preparations
IBA
10/2020 - 08/2014
3
Fingolimod Hydrochloride (FTY720)
FDA Link
11/2022 - 09/2016
3
COVID-19 Vaccines
IBA
11/2022 - 01/2022
3
Immunoglobulin M (IgM)
IBA
01/2022 - 10/2005
3
Atorvastatin (Lipitor)
FDA Link
02/2019 - 04/2010
2
Antigens
IBA
07/2022 - 11/2019
2
Epitopes
IBA
01/2022 - 07/2020
2
Peptides (Polypeptides)
IBA
01/2022 - 07/2020
2
Proteins (Proteins, Gene)
FDA Link
01/2022 - 10/2019
2
Immunoglobulin G (IgG)
IBA
12/2020 - 10/2005
2
Dronabinol (THC)
FDA Link
Generic
10/2020 - 01/2020
2
Cannabidiol
IBA
10/2020 - 01/2020
2
nabiximols (Sativex)
IBA
06/2020 - 01/2020
2
Alemtuzumab (Campath)
FDA Link
11/2019 - 01/2019
2
coenzyme Q10 (CoQ10)
IBA
09/2019 - 01/2019
2
Gadolinium
IBA
02/2019 - 12/2016
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2016 - 04/2010
2
Uric Acid (Urate)
IBA
04/2015 - 01/2015
1
N-acetyltalosaminuronic acid (NAT)
IBA
11/2022
1
Phosphates (Orthophosphate)
IBA
01/2022
1
Myelin Basic Protein
IBA
01/2022
1
Autoantibodies
IBA
01/2022
1
Immunoglobulins (Immunoglobulin)
IBA
01/2022
1
Sphingosine
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
Antioxidants
IBA
11/2021
1
Neuroprotective Agents
IBA
11/2021
1
Phytochemicals
IBA
11/2021
1
Curcumin
IBA
11/2021
1
GTP-Binding Proteins (G-Protein)
IBA
05/2021
1
Potassium Channels (Potassium Channel)
IBA
05/2021
1
Dimethyl Fumarate
IBA
04/2021
1
Amino Acid Transport Systems (Amino Acid Transporter)
IBA
01/2021
1
nitazoxanide (NTZ)
FDA Link
01/2021
1
Cytidine Diphosphate (CDP)
IBA
07/2020
1
Surface Antigens (Surface Antigen)
IBA
11/2019
1
Glucocorticoids
IBA
10/2019
1
Annexin A1
IBA
10/2019
1
Estrogens (Estrogen)
FDA Link
01/2018
1
Suspensions
IBA
01/2018
1
2-toluenesulfonamide (OTS)
IBA
08/2017
1
Vitamin K
FDA Link
08/2015
1
Nitrogen
IBA
04/2015
1
Oxygen (Dioxygen)
IBA
04/2015
1
Enzymes
IBA
01/2014
1
Immunosorbents
IBA
01/2014
1
DNA (Deoxyribonucleic Acid)
IBA
01/2014
1
C-Reactive Protein
IBA
01/2014
1
Contrast Media
IBA
03/2012
1
Apolipoproteins E (ApoE)
IBA
06/2006
1
Glycopeptides
IBA
10/2005
Therapy/Procedure
17
Therapeutics
11/2022 - 04/2010
2
Cognitive Training
02/2022 - 01/2018
1
Injections
05/2018